
Anondita Medicare Limited IPO
Anondita Medicare Limited IPO is a SME book building IPO. Price band is ₹145 per share. Minimum investment is ₹2.90 L. Lot size is 1000 shares. Open from 22 Aug 2025 to 26 Aug 2025. Allotment on 28 Aug 2025. Listing on 1 Sept 2025 at NSE. Managed by Narnolia Financial Services Ltd. Registrar: Maashitla Securities Private Limited. Key details for GMP, subscription, price, allotment, and listing in one place.
Anondita Medicare Limited IPO overview
Anondita Medicare Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Anondita Medicare Limited IPO important dates
Anondita Medicare Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,90,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,35,000 |
| S-HNI (UPI) | 3 | 3,000 | ₹4,35,000 |
| S-HNI (Max) | 6 | 6,000 | ₹8,70,000 |
| B-HNI (Min) | 7 | 7,000 | ₹10,15,000 |
About Anondita Medicare Limited IPO
From the company / RHP narrative.
The company has a manufacturing facility situated in Noida, Uttar Pradesh.
Anondita Medicare exports its products to several international markets, including Southeast Asia, Africa, and the Middle East.
The company collaborates with global health organizations, NGOs, and governments to support family planning and public health initiatives.
Anondita Medicare has a robust distribution network that ensures the timely delivery of its products to various markets.
The company collaborates with wholesalers, retailers, and e-commerce platforms to make its products widely accessible. It also has strong ties with government health programs and institutions, playing a key role in supplying essential medical products for public health initiatives.
As on July 31, 2025, the Company had 280 employees.
Competitive Strength:
Experienced and significant condom manufacturer in India.
Well-recognized in North India
Offers a diverse range of products.
Objective of the issue
How the issuer plans to use IPO proceeds.
Funding the Working Capital requirement
Unidentified Acquisition and General Corporate Purposes
Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Follow the latest IPO & unlisted research on iOS and Android.
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow the latest IPO & unlisted research on iOS and Android.